Inmune Bio (INMB) Shares Outstanding (2017 - 2026)
Inmune Bio (INMB) reported Shares Outstanding of 26.72 million for Q2 2026, up 14.7% from 23.3 million a year earlier and up 0.5% from the prior quarter.
Powered by 
Analysis
Inmune Bio (INMB) Shares Outstanding (2017 - 2026) Analysis & Trends
For FY2025, Inmune Bio posted Shares Outstanding of 24.76 million, up 24.1% from FY2024.
- Shares Outstanding has increased for eight consecutive years, with a five-year compound annual growth rate of 15.6% (FY2020 to FY2025).
- By year, Shares Outstanding came in at 19.94 million in FY2024 (+10.9%), 17.98 million in FY2023 (+0.3%), 17.93 million in FY2022 (+11.1%) and 16.13 million in FY2021 (+34.6%).
- The Q2 2026 figure ranks as the highest quarterly Shares Outstanding in data going back to Q4 2017.
- Year over year, Shares Outstanding has now increased in each of the last 12 quarters, with growth averaging 19.6% over the last eight quarters.
- The year-over-year growth in Shares Outstanding has ranged between 0.0% (Q2 2023) and 34.6% (Q4 2021) over the last five years.
- Per Business Quant data, the three quarters before Q2 2026 came in at 26.59 million (Q1 2026), 24.76 million (Q4 2025) and 26.59 million (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Shares Outstanding (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 638.12 Bn | 556.64 Bn | 17.26 Bn | 2.41 Bn |
| 2 | AbbVie | 462.60 Bn | 435.75 Bn | 12.70 Bn | 1.77 Bn |
| 3 | Merck | 358.70 Bn | 313.13 Bn | 12.21 Bn | 2.47 Bn |
| 4 | Novartis Ag | 272.16 Bn | 228.03 Bn | 11.24 Bn | 1.94 Bn |
| 5 | Astrazeneca | 250.36 Bn | 223.92 Bn | 12.86 Bn | 1.55 Bn |
| 6 | Amgen | 227.87 Bn | 183.27 Bn | 7.24 Bn | 540.00 Mn |
| 7 | Gilead Sciences | 184.97 Bn | 159.08 Bn | 6.22 Bn | 1.24 Bn |
| 8 | Pfizer | 162.61 Bn | 109.56 Bn | 10.94 Bn | 5.70 Bn |
| 9 | Vertex Pharmaceuticals | 132.45 Bn | 104.46 Bn | 2.84 Bn | 253.70 Mn |
| 10 | Inmune Bio | 53.92 Mn | -38.33 Mn | - | 26.72 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 26.72 Mn |
| Mar 31, 2026 | 26.59 Mn |
| Dec 31, 2025 | 24.76 Mn |
| Sep 30, 2025 | 26.59 Mn |
| Jun 30, 2025 | 23.30 Mn |
| Mar 31, 2025 | 22.50 Mn |
| Dec 31, 2024 | 19.94 Mn |
| Sep 30, 2024 | 20.19 Mn |
| Jun 30, 2024 | 19.31 Mn |
| Mar 31, 2024 | 18.03 Mn |
| Dec 31, 2023 | 17.98 Mn |
| Sep 30, 2023 | 18.01 Mn |
| Jun 30, 2023 | 17.95 Mn |
| Mar 31, 2023 | 17.95 Mn |
| Dec 31, 2022 | 17.93 Mn |
| Sep 30, 2022 | 17.95 Mn |
| Jun 30, 2022 | 17.95 Mn |
| Mar 31, 2022 | 17.87 Mn |
| Dec 31, 2021 | 16.13 Mn |
| Sep 30, 2021 | 17.33 Mn |
API Access
Inmune Bio Shares Outstanding API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=shares-outstanding&ticker=INMB&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "shares-outstanding", "ticker": "INMB", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=shares-outstanding&ticker=INMB&period=max&api_key=YOUR_API_KEY");
const data = await res.json();